Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lantheus Holdings, Inc.LNTH · Entity 690 | Director · 10% owner | March 17, 2017 | March 21, 2017 |
| OmniAb, Inc.AHPA · Entity 5294 | Executive Vice President | August 09, 2021 | August 09, 2021 |
| OptiNose, Inc.OPTN · Entity 79464 | Director · 10% owner | June 10, 2020 | June 12, 2020 |
| RVL Pharmaceuticals plcRVLP · Entity 108806 | Director · 10% owner | January 27, 2023 | January 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lantheus Holdings, Inc.
Report date March 17, 2017 · Filed March 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 7,004,395 |
Reported balance
After 2017-03-17 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-03-17 · Sale · Disposed 1,709,278 · Balance 7,004,395 F1: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,846,996 |
Reported balance
After 2017-03-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-03-17 · Sale · Disposed 450,722 · Balance 1,846,996 F2: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,442,208 |
Reported balance
After 2017-03-17 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-03-17 · Sale · Disposed 840,000 · Balance 3,442,208 F3: Represents shares of the Issuer held by ACP-Lantern Co-Invest, LLC ("ACP Co-Invest"). ACP GP is the manager of ACP Co-Invest. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Co-Invest. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F2: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
F3: Represents shares of the Issuer held by ACP-Lantern Co-Invest, LLC ("ACP Co-Invest"). ACP GP is the manager of ACP Co-Invest. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Co-Invest. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein.
OmniAb, Inc.
Report date August 09, 2021 · Filed August 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| No securities beneficially ownedSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-08-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
OptiNose, Inc.
Report date June 10, 2020 · Filed June 12, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.65 · Expires 2030-06-09 | Direct | 14,439 |
Reported balance
After 2020-06-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-10 · Grant · Acquired 14,439 · Balance 14,439 F1: The option vests and becomes exercisable on the earlier of (i) June 10, 2021 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2021 annual meeting of stockholders, subject to continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable on the earlier of (i) June 10, 2021 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2021 annual meeting of stockholders, subject to continued service with the Issuer.
RVL Pharmaceuticals plc
Report date January 27, 2023 · Filed January 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Avista Capital investment fund | 0 |
Reported balance
After 2023-01-27 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2023-01-27 · Other · Disposed 1,032,995 · Balance 0 F1: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration. F2: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Avista Capital investment fund | 23,730,864 |
Reported balance
Holding disclosure · report date 2023-01-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 23,730,864 F3: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration.
F2: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
F3: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2023 Filed Jan 30, 2023 17:28 UTC | RVL Pharmaceuticals plc RVLP · Entity 108806 | OtherOrdinary Shares | 1,032,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-008077 · tm234889-1_4seq1.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 F1 · kind: Represents shares distributed in kind by Orbit Co-Invest III LLC ("Orbit III") to its members, on a pro rata basis, for no consideration. F2 · ownership.nature: Represents shares of the Issuer held by Orbit III. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit III. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to have shared voting and investment power with respect to the shares held by Orbit III. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 17:19 UTC | RVL Pharmaceuticals plc RVLP · Entity 108806 | PurchaseOrdinary Shares | 8,000,000 | $1.55 | $12,400,000.00 |
DisclosureSEC source: 0001104659-22-088030 · tm2222999-2_4seq1.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 23,730,864 F1 · ownership.nature: Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| November 20, 2020 Filed Nov 23, 2020 17:13 UTC | RVL Pharmaceuticals plc OSMT · Entity 108806 | OtherOrdinary Shares | 4,936,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-20-128528 · a4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 F1 · kind: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. As a result, Mr. Venkataraman ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · shares: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. As a result, Mr. Venkataraman ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · price: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. As a result, Mr. Venkataraman ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. F1 · ownership.nature: Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC. Mr. Venkataraman is a member of the investment committee of ACP GP. As a result, Mr. Venkataraman ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 07:58 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $5.65 Strike: $5.65 | $81,580.35 |
DisclosureSEC source: 0001494650-20-000071 · wf-form4_159196308348724.xml · derivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2030-06-09 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 10, 2021 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2021 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 16:13 UTC | RVL Pharmaceuticals plc OSMT · Entity 108806 | PurchaseOrdinary Shares | 1,250,000 | $5.00 | $6,250,000.00 |
DisclosureSEC source: 0001104659-20-004324 · a4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 15,730,864 F1 · shares: Represents 1,250,000 Ordinary Shares acquired by Avista Healthcare Partners, L.P. ("AHP") in the Issuer's underwritten public offering (the "Offering") that was completed on January 13, 2020. The acquisition price of $5.00 per Ordinary Share represents the public offering price in the Offering paid by AHP and does not give effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of AHP, pursuant to the Fee Letter Agreement, dated January 8, 2020, among the Issuer, Avista Capital Holdings, L.P. and the other parties thereto, which was entered into in connection with the Offering. F1 · price: Represents 1,250,000 Ordinary Shares acquired by Avista Healthcare Partners, L.P. ("AHP") in the Issuer's underwritten public offering (the "Offering") that was completed on January 13, 2020. The acquisition price of $5.00 per Ordinary Share represents the public offering price in the Offering paid by AHP and does not give effect to the fee paid by the Issuer to Avista Capital Holdings, L.P., an affiliate of AHP, pursuant to the Fee Letter Agreement, dated January 8, 2020, among the Issuer, Avista Capital Holdings, L.P. and the other parties thereto, which was entered into in connection with the Offering. F2 · ownership.nature: Represents shares of the Issuer held by AHP. Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Venkataraman is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 17:36 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 70,762 | $9.17 | $648,533.73 |
DisclosureSEC source: 0000899243-19-028170 · doc4.xml · nonDerivative · entry 3 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 807,995 F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore) II-A, L.P. ("ACP Offshore II-A"). ACP II GP is the general partner of ACP Offshore II-A. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP Offshore II-A. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 17:36 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 291,516 | $9.17 | $2,671,744.14 |
DisclosureSEC source: 0000899243-19-028170 · doc4.xml · nonDerivative · entry 2 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,328,648 F2 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore) II, L.P. ("ACP Offshore II"). ACP II GP is the general partner of ACP Offshore II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP Offshore II. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 17:36 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 887,722 | $9.17 | $8,135,972.13 |
DisclosureSEC source: 0000899243-19-028170 · doc4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,136,374 F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners II, L.P. ("ACP II"). Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP II. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 10:49 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $6.60 Strike: $6.60 | $95,297.40 |
DisclosureSEC source: 0001494650-19-000057 · wf-form4_156017817828633.xml · derivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2029-06-05 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 6, 2020 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2020 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 16:50 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 162,754 | $20.92 | $3,403,999.91 |
DisclosureSEC source: 0000899243-18-016384 · doc4.xml · nonDerivative · entry 3 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 878,757 F3 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore) II-A, L.P. ("ACP Offshore II-A"). ACP II GP is the general partner of ACP Offshore II-A. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP Offshore II-A. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 16:50 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 670,487 | $20.92 | $14,023,235.61 |
DisclosureSEC source: 0000899243-18-016384 · doc4.xml · nonDerivative · entry 2 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,620,164 F2 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore) II, L.P. ("ACP Offshore II"). ACP II GP is the general partner of ACP Offshore II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP Offshore II. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 16:50 UTC | OptiNose, Inc. OPTN · Entity 79464 | SaleCommon Stock | 2,041,759 | $20.92 | $42,703,389.49 |
DisclosureSEC source: 0000899243-18-016384 · doc4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,024,096 F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners II, L.P. ("ACP II"). Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share beneficial ownership of the shares of common stock held by ACP II. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 17:27 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantStock Option (Right to Buy) · Derivative | 14,439 | $22.50 Strike: $22.50 | $324,877.50 |
DisclosureSEC source: 0001494650-18-000068 · wf-form4_152875245821562.xml · derivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,439 Underlying: Common Stock · 14,439 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 7, 2019 (the one-year anniversary of the date of grant) and (ii) the Issuer's 2019 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries D Convertible Preferred Stock · Derivative | 17,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 18 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 49,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries D Convertible Preferred Stock · Derivative | 216,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 17 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 205,023 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries D Convertible Preferred Stock · Derivative | 216,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 16 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 624,332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-2 Convertible Preferred Stock · Derivative | 28,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 15 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 81,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-2 Convertible Preferred Stock · Derivative | 116,529 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 14 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 336,524 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-2 Convertible Preferred Stock · Derivative | 354,855 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 13 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 1,024,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-1 Convertible Preferred Stock · Derivative | 65,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 12 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 189,911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-1 Convertible Preferred Stock · Derivative | 270,915 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 11 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 782,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C-1 Convertible Preferred Stock · Derivative | 824,986 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 10 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 2,382,477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C Convertible Preferred Stock · Derivative | 222,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 9 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 641,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C Convertible Preferred Stock · Derivative | 914,916 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 8 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 2,642,185 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionSeries C Convertible Preferred Stock · Derivative | 2,786,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · derivative · entry 7 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 0 Underlying: Common Stock · 8,045,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F7 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionCommon Stock | 962,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 6 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 1,041,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares of the Issuer received by Avista Capital Partners (Offshore) II-A, LP ("ACP II-A Offshore") upon the conversion of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock upon the closing of the Issuer's initial public offering. F7 · price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionCommon Stock | 3,966,107 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 5 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 4,290,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of the Issuer received by Avista Capital Partners (Offshore) II, L.P. ("ACP II Offshore") upon the conversion of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock upon the closing of the Issuer's initial public offering. F7 · price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | ConversionCommon Stock | 12,077,563 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 4 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 13,065,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of the Issuer received by Avista Capital Partners II, L.P. ("ACP II") upon the conversion of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock upon the closing of the Issuer's initial public offering. F7 · price: Each share of Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into Common Stock on a 1-for-2.8879 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock, Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock and Series D Convertible Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering and had no expiration date. F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantCommon Stock | 70,763 | $16.00 | $1,132,208.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 3 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 1,041,511 F6 · ownership.nature: Represents shares of the Issuer held by ACP II-A Offshore. ACP II GP is the general partner of ACP II-A Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II-A Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantCommon Stock | 291,516 | $16.00 | $4,664,256.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 2 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 4,290,651 F5 · ownership.nature: Represents shares of the Issuer held by ACP II Offshore. ACP II GP is the general partner of ACP II Offshore. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II Offshore. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| October 17, 2017 Filed Oct 19, 2017 17:38 UTC | OptiNose, Inc. OPTN · Entity 79464 | GrantCommon Stock | 887,721 | $16.00 | $14,203,536.00 |
DisclosureSEC source: 0000899243-17-024502 · doc4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Avista Capital investment fund Disclosed balance after: 988,292 F4 · ownership.nature: Represents shares of the Issuer held by ACP II. Avista Capital Partners II GP, LLC ("ACP II GP") is the general partner of ACP II. Mr. Venkataraman is a member of the investment committee of ACP II GP. By virtue of this relationship, Mr. Venkataraman may be deemed to share voting and investment power with respect to the shares held by ACP II. Mr. Venkataraman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 21:00 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 840,000 | $12.20 | $10,248,000.00 |
DisclosureSEC source: 0000899243-17-008307 · doc4.xml · nonDerivative · entry 3 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,442,208 F3 · ownership.nature: Represents shares of the Issuer held by ACP-Lantern Co-Invest, LLC ("ACP Co-Invest"). ACP GP is the manager of ACP Co-Invest. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Co-Invest. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 21:00 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 450,722 | $12.20 | $5,498,808.40 |
DisclosureSEC source: 0000899243-17-008307 · doc4.xml · nonDerivative · entry 2 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,846,996 F2 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 21:00 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 1,709,278 | $12.20 | $20,853,191.60 |
DisclosureSEC source: 0000899243-17-008307 · doc4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,004,395 F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:33 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 700,000 | $9.00 | $6,300,000.00 |
DisclosureSEC source: 0000899243-16-034337 · doc4.xml · nonDerivative · entry 3 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,282,208 F3 · ownership.nature: Represents shares of the Issuer held by ACP-Lantern Co-Invest, LLC ("ACP Co-Invest"). ACP GP is the manager of ACP Co-Invest. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Co-Invest. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:33 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 375,601 | $9.00 | $3,380,409.00 |
DisclosureSEC source: 0000899243-16-034337 · doc4.xml · nonDerivative · entry 2 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,297,718 F2 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners (Offshore), L.P. ("ACP Offshore"). ACP GP is the general partner of ACP Offshore. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP Offshore. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 21:33 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 1,424,399 | $9.00 | $12,819,591.00 |
DisclosureSEC source: 0000899243-16-034337 · doc4.xml · nonDerivative · entry 1 Venkataraman Sriram · CIK 0001550642 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,713,673 F1 · ownership.nature: Represents shares of the Issuer held by Avista Capital Partners, L.P. ("ACP"). Avista Capital Partners GP, LLC ("ACP GP") is the general partner of ACP. Mr. Venkataraman is a member of the investment committee of ACP GP. By virtue of these relationships, Mr. Venkataraman may be deemed to share voting and dispositive power with respect to the shares of common stock held by ACP. Mr. Venkataraman expressly disclaims beneficial ownership of any such securities, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.